131 related articles for article (PubMed ID: 23754473)
1. Craniospinal irradiation with concurrent temozolomide and nimotuzumab in a child with primary metastatic diffuse intrinsic pontine glioma. A compassionate use treatment.
Müller K; Schlamann A; Seidel C; Warmuth-Metz M; Christiansen H; Vordermark D; Kortmann RD; Kramm CM; von Bueren AO
Strahlenther Onkol; 2013 Aug; 189(8):693-6. PubMed ID: 23754473
[TBL] [Abstract][Full Text] [Related]
2. Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.
Müller K; Schlamann A; Guckenberger M; Warmuth-Metz M; Glück A; Pietschmann S; Wawer A; Kortmann RD; Kramm C; von Bueren AO
Strahlenther Onkol; 2014 Apr; 190(4):377-81. PubMed ID: 24638239
[TBL] [Abstract][Full Text] [Related]
3. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).
Bailey S; Howman A; Wheatley K; Wherton D; Boota N; Pizer B; Fisher D; Kearns P; Picton S; Saran F; Gibson M; Glaser A; Connolly DJ; Hargrave D
Eur J Cancer; 2013 Dec; 49(18):3856-62. PubMed ID: 24011536
[TBL] [Abstract][Full Text] [Related]
4. Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma.
Özkan A; Yağcı Küpeli B; Küpeli S; Sezgin G; Bayram İ
Childs Nerv Syst; 2024 Jun; 40(6):1671-1680. PubMed ID: 38478066
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
6. Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab.
Zaky W; Wellner M; Brown RJ; Blüml S; Finlay JL; Dhall G
Pediatr Hematol Oncol; 2013 Oct; 30(7):623-32. PubMed ID: 24050762
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
Chassot A; Canale S; Varlet P; Puget S; Roujeau T; Negretti L; Dhermain F; Rialland X; Raquin MA; Grill J; Dufour C
J Neurooncol; 2012 Jan; 106(2):399-407. PubMed ID: 21858607
[TBL] [Abstract][Full Text] [Related]
8. Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.
Fleischhack G; Massimino M; Warmuth-Metz M; Khuhlaeva E; Janssen G; Graf N; Rutkowski S; Beilken A; Schmid I; Biassoni V; Gorelishev SK; Kramm C; Reinhard H; Schlegel PG; Kortmann RD; Reuter D; Bach F; Iznaga-Escobar NE; Bode U
J Neurooncol; 2019 May; 143(1):107-113. PubMed ID: 30830679
[TBL] [Abstract][Full Text] [Related]
9. Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma.
Sirachainan N; Pakakasama S; Visudithbhan A; Chiamchanya S; Tuntiyatorn L; Dhanachai M; Laothamatas J; Hongeng S
Neuro Oncol; 2008 Aug; 10(4):577-82. PubMed ID: 18559468
[TBL] [Abstract][Full Text] [Related]
10. Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
Kebudi R; Cakir FB; Bay SB; Gorgun O; Altınok P; Iribas A; Agaoglu FY; Darendeliler E
Childs Nerv Syst; 2019 Jan; 35(1):83-89. PubMed ID: 30417211
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Impact of Radiotherapy in Conjunction with Temozolomide in Diffuse Intrinsic Pontine Glioma: A Systematic Review and Meta-Analysis.
Shi S; Lu S; Jing X; Liao J; Li Q
World Neurosurg; 2021 Apr; 148():e565-e571. PubMed ID: 33476781
[TBL] [Abstract][Full Text] [Related]
12. Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.
Seidel C; von Bueren AO; Bojko S; Hoffmann M; Pietsch T; Gielen GH; Warmuth-Metz M; Bison B; Kortmann RD; Kramm CM
Strahlenther Onkol; 2018 Mar; 194(3):215-224. PubMed ID: 29022050
[TBL] [Abstract][Full Text] [Related]
13. Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
Massimino M; Biassoni V; Miceli R; Schiavello E; Warmuth-Metz M; Modena P; Casanova M; Pecori E; Giangaspero F; Antonelli M; Buttarelli FR; Potepan P; Pollo B; Nunziata R; Spreafico F; Podda M; Anichini A; Clerici CA; Sardi I; De Cecco L; Bode U; Bach F; Gandola L
J Neurooncol; 2014 Jun; 118(2):305-312. PubMed ID: 24696052
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated radiotherapy with temozolomide in diffuse intrinsic pontine gliomas: a randomized controlled trial.
Izzuddeen Y; Gupta S; Haresh KP; Sharma D; Giridhar P; Rath GK
J Neurooncol; 2020 Jan; 146(1):91-95. PubMed ID: 31728883
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.
Aguilera DG; Mazewski C; Hayes L; Jordan C; Esiashivilli N; Janns A; Macdonald TJ
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e42-6. PubMed ID: 23249962
[TBL] [Abstract][Full Text] [Related]
16. [Safety and efficacy of three-dimensional conformal radiotherapy combined with temozolomide in treatment of diffuse brainstem gliomas].
Fang HH; Nie Q; Kang JB; Li FM; Cai CL
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):707-9. PubMed ID: 22340055
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
[TBL] [Abstract][Full Text] [Related]
18. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Jakacki RI; Cohen KJ; Buxton A; Krailo MD; Burger PC; Rosenblum MK; Brat DJ; Hamilton RL; Eckel SP; Zhou T; Lavey RS; Pollack IF
Neuro Oncol; 2016 Oct; 18(10):1442-50. PubMed ID: 27006176
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?
Rizzo D; Scalzone M; Ruggiero A; Maurizi P; Attinà G; Mastrangelo S; Lazzareschi I; Ridola V; Colosimo C; Caldarelli M; Balducci M; Riccardi R
J Chemother; 2015 Feb; 27(2):106-10. PubMed ID: 25466729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
